REMOTEA STORY – SO FAR
Ever since the founding in 2002 Remotea has strived to enable faster and more efficient diagnosis of patients. We set off with sleep apnea remote services, and today we are a well-established medical technology company expanded to cardiac data analytics, versatile remote diagnostics services and medical devices.
The story goes further beyond to the 1980’s where a persistent team of technical and medical professionals strived to develop executable sleep apnea diagnosis methods.
Behind many successes we can find a team of individuals with strong vision and determination, and that is the case here too. A young physicist Pekka Tiihonen joined a team working on neurophysiological diagnostics, especially EEG-telemetry, in a hospital at the eastern part of Finland bringing technical expertise to the team. At the time, sleep apnea analysis was quite rare and qualitative as the devices where based on expensive EEG-recorders, and therefore measuring and screening sleep apnea was unsystematic.
The team started to develop devices suitable to use at home. The first four-channel portable device was produced by Tiihonen’s team in 1989.
The sleep briefcase was able to identify clear sleep apnea cases, but it was not possible to analyze and classify them precisely. At that time the embedded device operated independently and produced respiration signal curves after recording to Windows environment, says Tiihonen. After twenty years those raw curves have been re-analyzed and several scientific articles have been published.
The so-called sleep briefcase was in use the following 14 years, while the team worked simultaneously to improve its accuracy and usability. Venla, the first sleep apnea device aimed entirely for home use was completed in 2002. Later Pekka Tiihonen started to work on his doctoral thesis “Novel Portable Devices for Recording Sleep Apnea and Evaluating Altered Consciousness”, which was published and accepted in 2009.
Pivoting towards software development
Remotea AB was founded in 2009 in Sweden and big data analysis and first software development was started.
The first working prototype of SmartECG™ software was developed in 2013 and it was internally validated in 2016. In same year Remotea’s new consultation platform was also developed and company reached a client base of 250 clinics.
Remotea as a software development company
2017 Remote Analysis Oy was sold to Coronaria Terveyspalvelut. Remotea continued to provide the Medical remote diagnostic service platform and telemedicine platform to Coronoria Analyysipalvelut Oy.
In same year Remotea Oy raised EUR 1.2 million in funding from the EU to develop the official version of SmartECG™ software for automatic analysis of ECG.
2018 Bittium Medanalytics Oy purchased Remotea’s medical remote diagnostic service platform and the product rights of the related medical measurement devices and their interfaces. Remotea concentrates on the development of cardiac analytics and the SmartECG™ software.
CE Certification of SmartECG™
2019 Remotea completed the CE certification process for SmartECG™ software and now the product meets the requirements of the Medical Directive 93/42/EEC. SmartECG 1.0 was piloted and launched. Remotea is developing the SmartECG™ version 2.0 and we expect the SmartECG™ Version 2.0 to be CE certified and launched in 2020.
THE KEY MILESTONES
2002: Company was founded by Mr. Ossi Tiihonen to commercialize sleep apnea telemedicine platform
2005: Launching of the Remotea´s ECG telemedicine consultation service in Finland
2007: Expansion to UK; breakeven point for consultation service
2009: Expansion to Sweden; database of 5000 ECG analysis reports; beginning of big data analysis and first software development
2013: First working prototype of SmartECG™ algorithm software
2016: Internal validation of the SmartECG™ algorithm; new consultation platform development; reached client base of 250 clinics
2017: Remote Analysis Oy was sold to Coronaria Terveyspalvelut. Remotea continues to provide the software solution and telemedicine platform for Coronaria Analyysipalvelut Oy.
2017: Remotea Oy has raised EUR 1.2 million in funding from the EU to develop SmartECG™, an algorithm-based software product for automatically analysing ECG. Of the 104 ICT companies that applied for the funding, only four companies were chosen, with Remotea receiving the highest scores
2018: Bittium Medanalytics Oy purchases Remotea’s medical remote diagnostic service platform and the product rights of the related medical measurement devices and their interfaces. Remotea concentrates on the development of cardiac analytics and the SmartECG™ Software.
2019: The CE certification process is completed and the product meets the requirements of the Medical Device Directive 93/42/EEC.
2019: Piloting and launch of the SmartECG™ Software 1.0
2020: Launch of the SmartECG™ Software 2.0
SOME OF OUR CLIENTS AND PARTNERS
Remotea is a healthtech software company.
We help patients get to treatment faster, healthcare professionals to use their resources in a better way and health and wellness operators to give more value to their customers.
SmartECG™ is a CE certified medical software for viewing and analyzing ambulatory ECGs such as Holter recordings.
© Copyright 2020 Remotea Ltd